| Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 82 (5), 299-308, 2003 | 1771 | 2003 |
| Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD SEBASTIANI, A Gil, P Lavilla, ... Medicine 72 (2), 113-124, 1993 | 1342 | 1993 |
| Immunosuppressive therapy in lupus nephritis: the Euro‐Lupus Nephritis Trial, a randomized trial of low‐dose versus high‐dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ER Garrido, ... Arthritis & Rheumatism 46 (8), 2121-2131, 2002 | 1302 | 2002 |
| Morbidity and mortality in systemic lupus erythematosus during a 5-year period: a multicenter prospective study of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 78 (3), 167-175, 1999 | 594 | 1999 |
| The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide FA Houssiau, C Vasconcelos, D D’Cruz, GD Sebastiani, ... Annals of the rheumatic diseases 69 (01), 61-64, 2010 | 593 | 2010 |
| Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long‐term followup of patients in the Euro‐Lupus Nephritis Trial FA Houssiau, C Vasconcelos, D D'Cruz, GD Sebastiani, ... Arthritis & rheumatism 50 (12), 3934-3940, 2004 | 466 | 2004 |
| miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis V Fulci, G Scappucci, GD Sebastiani, C Giannitti, D Franceschini, ... Human immunology 71 (2), 206-211, 2010 | 295 | 2010 |
| Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis R Lande, E Giacomini, B Serafini, B Rosicarelli, GD Sebastiani, ... The Journal of immunology 173 (4), 2815-2824, 2004 | 190 | 2004 |
| Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study M Suarez-Gestal, M Calaza, E Endreffy, R Pullmann, J Ordi-Ros, ... Arthritis research & therapy 11, 1-9, 2009 | 172 | 2009 |
| Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ... Journal of clinical medicine 8 (11), 2013, 2019 | 164 | 2019 |
| Autoinflammatory syndromes M Galeazzi, G Gasbarrini, A Ghirardello, S Grandemange, HM Hoffman, ... Clinical and experimental rheumatology 24 (1), S79, 2006 | 155 | 2006 |
| Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies … M Galeazzi, G Morozzi, GD Sebastiani, F Bellisai, R Marcolongo, ... Clinical and experimental rheumatology 16 (5), 541-546, 1998 | 135 | 1998 |
| Two single‐nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus S D'Alfonso, N Barizzone, M Giordano, A Chiocchetti, C Magnani, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2005 | 131 | 2005 |
| How do patients with newly diagnosed systemic lupus erythematosus present? A multicenter cohort of early systemic lupus erythematosus to inform the development of new … M Mosca, KH Costenbader, SR Johnson, V Lorenzoni, GD Sebastiani, ... Arthritis & Rheumatology 71 (1), 91-98, 2019 | 129 | 2019 |
| Kallikrein genes are associated with lupus and glomerular basement membrane–specific antibody–induced nephritis in mice and humans K Liu, QZ Li, AM Delgado-Vega, AK Abelson, E Sánchez, JA Kelly, L Li, ... The Journal of clinical investigation 119 (4), 911-923, 2009 | 128 | 2009 |
| Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study N Bizzaro, E Bartoloni, G Morozzi, S Manganelli, V Riccieri, P Sabatini, ... Arthritis research & therapy 15, 1-9, 2013 | 105 | 2013 |
| Anticardiolipin and anti-β2GPI antibodies in a large series of European patients with systemic lupus erythematosus GD Sebastiani, M Galeazzi, A Tincani, JC Piette, J Font, F Allegri, ... Scandinavian journal of rheumatology 28 (6), 344-351, 1999 | 99 | 1999 |
| HLA class II alleles associations of anticardiolipin and anti b2GPI antibodies in a large series of European patients with systemic lupus erythematosus M Galeazzi, GD Sebastiani, A Tincani, JC Piette, F Allegri, G Morozzi, ... Lupus 9 (1), 47-55, 2000 | 93 | 2000 |
| Anti-ganglioside antibodies in a large cohort of European patients with systemic lupus erythematosus: clinical, serological, and HLA class II gene associations. European … M Galeazzi, P Annunziata, GD Sebastiani, F Bellisai, V Campanella, ... The Journal of Rheumatology 27 (1), 135-141, 2000 | 80 | 2000 |
| Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome L Cantarini, OM Lucherini, R Cimaz, CT Baldari, F Bellisai, SR Paccani, ... International Journal of Immunopathology and Pharmacology 22 (4), 1051-1058, 2009 | 79 | 2009 |
